Neuropeptide regulation of non-redundant ILC2 responses at barrier surfaces.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
11 2022
Historique:
received: 10 10 2021
accepted: 31 08 2022
pubmed: 4 11 2022
medline: 26 11 2022
entrez: 3 11 2022
Statut: ppublish

Résumé

Emerging studies indicate that cooperation between neurons and immune cells regulates antimicrobial immunity, inflammation and tissue homeostasis. For example, a neuronal rheostat provides excitatory or inhibitory signals that control the functions of tissue-resident group 2 innate lymphoid cells (ILC2s) at mucosal barrier surfaces

Identifiants

pubmed: 36323781
doi: 10.1038/s41586-022-05297-6
pii: 10.1038/s41586-022-05297-6
pmc: PMC10225046
mid: NIHMS1895663
doi:

Substances chimiques

Cytokines 0
Neuropeptides 0
Cre recombinase EC 2.7.7.-
NMUR1 protein, human 0
Nmur1 protein, mouse 0
neuromedin U 117505-80-3
Amphiregulin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

787-793

Subventions

Organisme : NIAID NIH HHS
ID : R21 AI142213
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI095466
Pays : United States
Organisme : NIMH NIH HHS
ID : K08 MH130773
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK132244
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK126871
Pays : United States
Organisme : European Research Council
ID : 803087
Pays : International
Organisme : NIAID NIH HHS
ID : R01 AI172027
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI095608
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR070116
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK110352
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK121009
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI151599
Pays : United States

Investigateurs

Randy Longman (R)
Gregory Sonnenberg (G)
Ellen Scherl (E)
Dana Lukin (D)
Robert Battat (R)
Robbyn Sockolow (R)
Thomas Ciecierega (T)
Aliza Solomon (A)
Elaine Barfield (E)
Kimberley Chien (K)
Johanna Ferreira (J)
Jasmin Williams (J)
Shaira Khan (S)
Peik Sean Chong (PS)
Samah Mozumder (S)
Lance Chou (L)
Wenqing Zhou (W)
Anees Ahmed (A)
Ann M Joseph (AM)

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Chu, C., Artis, D. & Chiu, I. M. Neuro-immune interactions in the tissues. Immunity 52, 464–474 (2020).
pubmed: 32187517
Huh, J. R. & Veiga-Fernandes, H. Neuroimmune circuits in inter-organ communication. Nat. Rev. Immunol. 20, 217–228 (2020).
pubmed: 31848462
Veiga-Fernandes, H. & Artis, D. Neuronal–immune system cross-talk in homeostasis. Science 359, 1465–1466 (2018).
pubmed: 29599230
Yano, H. & Artis, D. Neuronal regulation of innate lymphoid cell responses. Curr. Opin. Immunol. 76, 102205 (2022).
pubmed: 35569418
Klose, C. S. N. et al. The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation. Nature 549, 282–286 (2017).
pubmed: 28869965 pmcid: 6066372
Cardoso, V. et al. Neuronal regulation of type 2 innate lymphoid cells via neuromedin U. Nature 549, 277–281 (2017).
pubmed: 28869974 pmcid: 5714273
Wallrapp, A. et al. The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation. Nature 549, 351–356 (2017).
pubmed: 28902842 pmcid: 5746044
Brestoff, J. R. & Artis, D. Immune regulation of metabolic homeostasis in health and disease. Cell 161, 146–160 (2015).
pubmed: 25815992 pmcid: 4400287
Klose, C. S. & Artis, D. Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. Nat. Immunol. 17, 765–774 (2016).
pubmed: 27328006
Zaiss, D. M. W., Gause, W. C., Osborne, L. C. & Artis, D. Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair. Immunity 42, 216–226 (2015).
pubmed: 25692699 pmcid: 4792035
Monticelli, L. A. et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 12, 1045–1054 (2011).
pubmed: 21946417 pmcid: 3320042
Monticelli, L. A. et al. IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin–EGFR interactions. Proc. Natl Acad. Sci. USA 112, 10762–10767 (2015).
pubmed: 26243875 pmcid: 4553775
Colonna, M. Innate lymphoid cells: diversity, plasticity, and unique functions in immunity. Immunity 48, 1104–1117 (2018).
pubmed: 29924976 pmcid: 6344351
Sonnenberg, G. F. & Hepworth, M. R. Functional interactions between innate lymphoid cells and adaptive immunity. Nat. Rev. Immunol. 19, 599–613 (2019).
pubmed: 31350531 pmcid: 6982279
Vivier, E. et al. Innate lymphoid cells: 10 years on. Cell 174, 1054–1066 (2018).
pubmed: 30142344
Guia, S. & Narni-Mancinelli, E. Helper-like innate lymphoid cells in humans and mice. Trends Immunol. 41, 436–452 (2020).
pubmed: 32223931
Ebbo, M., Crinier, A., Vély, F. & Vivier, E. Innate lymphoid cells: major players in inflammatory diseases. Nat. Rev. Immunol. 17, 665–678 (2017).
pubmed: 28804130
Chu, C. et al. The ChAT–acetylcholine pathway promotes group 2 innate lymphoid cell responses and anti-helminth immunity. Sci. Immunol. 6, eabe3218 (2021).
pubmed: 33674322 pmcid: 8577047
Moriyama, S. et al. β
pubmed: 29496881
Nagashima, H. et al. Neuropeptide CGRP limits group 2 innate lymphoid cell responses and constrains type 2 inflammation. Immunity 51, 682–695.e6 (2019).
pubmed: 31353223 pmcid: 6801073
Wallrapp, A. et al. Calcitonin gene-related peptide negatively regulates Alarmin-driven type 2 innate lymphoid cell responses. Immunity 51, 709–723.e706 (2019).
pubmed: 31604686 pmcid: 7076585
Xu, H. et al. Transcriptional atlas of intestinal immune cells reveals that neuropeptide α-CGRP modulates group 2 innate lymphoid cell responses. Immunity 51, 696–708.e9 (2019).
pubmed: 31618654 pmcid: 6991097
Hepworth, M. R. et al. Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4
pubmed: 25908663 pmcid: 4449822
Zhou, L. et al. Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2. Nature 568, 405–409 (2019).
pubmed: 30944470 pmcid: 6481643
Vély, F. et al. Evidence of innate lymphoid cell redundancy in humans. Nat. Immunol. 17, 1291–1299 (2016).
pubmed: 27618553 pmcid: 5074366
Shimshek, D. R. et al. Codon-improved Cre recombinase (iCre) expression in the mouse. Genesis 32, 19–26 (2002).
pubmed: 11835670
Cormack, B. P., Valdivia, R. H. & Falkow, S. FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173, 33–38 (1996).
pubmed: 8707053
Luche, H., Weber, O., Nageswara Rao, T., Blum, C. & Fehling, H. J. Faithful activation of an extra-bright red fluorescent protein in “knock-in” Cre-reporter mice ideally suited for lineage tracing studies. Eur. J. Immunol. 37, 43–53 (2007).
pubmed: 17171761
Brestoff, J. R. et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 519, 242–246 (2015).
pubmed: 25533952
Nussbaum, J. C. et al. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 502, 245–248 (2013).
pubmed: 24037376 pmcid: 3795960
Schlenner, S. M. et al. Fate mapping reveals separate origins of T cells and myeloid lineages in the thymus. Immunity 32, 426–436 (2010).
pubmed: 20303297
Oliphant, C. J. et al. MHCII-mediated dialog between group 2 innate lymphoid cells and CD4
pubmed: 25088770 pmcid: 4148706
Klementowicz, J. E., Travis, M. A. & Grencis, R. K. Trichuris muris: a model of gastrointestinal parasite infection. Semin. Immunopathol. 34, 815–828 (2012).
pubmed: 23053395 pmcid: 3496546
Zaiss, D. M. et al. Amphiregulin, a TH2 cytokine enhancing resistance to nematodes. Science 314, 1746 (2006).
pubmed: 17170297
Shao, J. & Sheng, H. Amphiregulin promotes intestinal epithelial regeneration: roles of intestinal subepithelial myofibroblasts. Endocrinology 151, 3728–3737 (2010).
pubmed: 20534719 pmcid: 2940516
Manzo, N. D., Foster, W. M. & Stripp, B. R. Amphiregulin-dependent mucous cell metaplasia in a model of nonallergic lung injury. Am. J. Respir. Cell Mol. Biol. 47, 349–357 (2012).
pubmed: 22493011 pmcid: 3488692
Zeisel, A. et al. Molecular architecture of the mouse nervous system. Cell 174, 999–1014.e22 (2018).
pubmed: 30096314 pmcid: 6086934
Antignano, F., Mullaly, S. C., Burrows, K. & Zaph, C. Trichuris muris infection: a model of type 2 immunity and inflammation in the gut. J. Vis. Exp. https://doi.org/10.3791/2774 (2011).
Arpaia, N. et al. A distinct function of regulatory T cells in tissue protection. Cell 162, 1078–1089 (2015).
pubmed: 26317471 pmcid: 4603556
Burzyn, D. et al. A special population of regulatory T cells potentiates muscle repair. Cell 155, 1282–1295 (2013).
pubmed: 24315098 pmcid: 3894749
Minutti, C. M. et al. Epidermal growth factor receptor expression licenses type-2 helper T cells to function in a T cell receptor-independent fashion. Immunity 47, 710–722.e6 (2017).
pubmed: 29045902 pmcid: 5654729
De Salvo, C. et al. NOD2 drives early IL-33-dependent expansion of group 2 innate lymphoid cells during Crohn’s disease-like ileitis. J. Clin. Invest. 131, e140624 (2021).
pubmed: 33444291 pmcid: 7919719
Inclan-Rico, J. M. et al. Basophils prime group 2 innate lymphoid cells for neuropeptide-mediated inhibition. Nat. Immunol. 21, 1181–1193 (2020).
pubmed: 32807943 pmcid: 9357342
Arijs, I. et al. Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis. Gut 58, 1612–1619 (2009).
pubmed: 19700435
Ye, Y. et al. Neuromedin U promotes human type 2 immune responses. Mucosal Immunol. 15, 990–999 (2022).
pubmed: 35810259 pmcid: 9385483
Jarick, K. J. et al. Non-redundant functions of group 2 innate lymphoid cells. Nature https://doi.org/10.1038/s41586-022-05395-5 (2022).
Buch, T. et al. A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat. Methods 2, 419–426 (2005).
pubmed: 15908920
Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133–140 (2010).
pubmed: 20023653
Lee, P. P. et al. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15, 763–774 (2001).
pubmed: 11728338
Luetteke, N. C. et al. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 126, 2739–2750 (1999).
pubmed: 10331984
He, Z. et al. Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc
pubmed: 28710436 pmcid: 5511216
Longman, R. S. et al. CX
pubmed: 25024136 pmcid: 4113938
Simoni, Y. et al. Human innate lymphoid cell subsets possess tissue-type based heterogeneity in phenotype and frequency. Immunity 46, 148–161 (2017).
pubmed: 27986455
Artis, D. et al. The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. J. Immunol. 173, 5626–5634 (2004).
pubmed: 15494513
Susaki, E. A. et al. Whole-brain imaging with single-cell resolution using chemical cocktails and computational analysis. Cell 157, 726–739 (2014).
pubmed: 24746791
MacDonald, J. W. affycoretools: Functions useful for those doing repetitive analyses with Affymetrix GeneChips. R package version 1.68.1 (2022).
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
pubmed: 23104886
Liao, Y., Smyth, G. K. & Shi, W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res. 47, e47 (2019).
pubmed: 30783653 pmcid: 6486549
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
pubmed: 25516281 pmcid: 4302049

Auteurs

Amy M Tsou (AM)

Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, New York, NY, USA.
Division of Pediatric Gastroenterology, Hepatology and Nutrition, Weill Cornell Medical College, New York, NY, USA.

Hiroshi Yano (H)

Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, New York, NY, USA.
Joan and Sanford I. Weill Department of Medicine, Division of Gastroenterology and Hepatology, Weill Cornell Medicine, Cornell University, New York, NY, USA.
Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, New York, NY, USA.

Christopher N Parkhurst (CN)

Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, New York, NY, USA.
Joan and Sanford I. Weill Department of Medicine, Division of Gastroenterology and Hepatology, Weill Cornell Medicine, Cornell University, New York, NY, USA.
Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, New York, NY, USA.

Tanel Mahlakõiv (T)

Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, New York, NY, USA.

Coco Chu (C)

Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, New York, NY, USA.

Wen Zhang (W)

Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, New York, NY, USA.
Joan and Sanford I. Weill Department of Medicine, Division of Gastroenterology and Hepatology, Weill Cornell Medicine, Cornell University, New York, NY, USA.
Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, New York, NY, USA.

Zhengxiang He (Z)

Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Katja J Jarick (KJ)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Microbiology, Infectious Diseases and Immunology, Berlin, Germany.

Connie Zhong (C)

Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, New York, NY, USA.

Gregory G Putzel (GG)

Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, New York, NY, USA.

Mai Hatazaki (M)

Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, New York, NY, USA.

Ivo C Lorenz (IC)

Tri-Institutional Therapeutics Discovery Institute, New York, NY, USA.

David Andrew (D)

Tri-Institutional Therapeutics Discovery Institute, New York, NY, USA.

Paul Balderes (P)

Tri-Institutional Therapeutics Discovery Institute, New York, NY, USA.

Christoph S N Klose (CSN)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Microbiology, Infectious Diseases and Immunology, Berlin, Germany.

Sergio A Lira (SA)

Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

David Artis (D)

Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, New York, NY, USA. dartis@med.cornell.edu.
Joan and Sanford I. Weill Department of Medicine, Division of Gastroenterology and Hepatology, Weill Cornell Medicine, Cornell University, New York, NY, USA. dartis@med.cornell.edu.
Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, New York, NY, USA. dartis@med.cornell.edu.
Friedman Center for Nutrition and Inflammation, Joan and Sanford I. Weill Department of Medicine, Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, New York, NY, USA. dartis@med.cornell.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH